Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06555939 · ClinicalTrials.gov registry record · NA

Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease

A NA study of Sickle Cell Disease, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06555939 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 25 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06555939, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

Adolescents and young adults with sickle cell disease (SCD) face challenges managing their illness and maintaining their well-being. This study proposes to test the feasibility and acceptability of a resilience-promoting intervention through a Collaborative Care Model. The primary goal is to determine with the resilience intervention (PRISM) is feasible and acceptable for adolescents and young adults with SCD. Exploratory outcomes include whether this intervention improves depression, anxiety, and pain interference.

Conditions Studied

Sickle Cell Disease

Interventions

  • BEHAVIORAL Collaborative Care Model
  • BEHAVIORAL Promoting Resilience in Stress Management

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2025-10-23
Est. Completion 2030-09
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06555939

The ClinicalTrials.gov registry entry for NCT06555939 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (91% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which Collaborative Care Model is the first listed.

NCT06555939 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06555939 about?

NCT06555939 is a clinical study titled "Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease". Adolescents and young adults with sickle cell disease (SCD) face challenges managing their illness and maintaining their well-being. This study proposes to test the feasibility and acceptability of a resilience-promoting intervention through a Collaborative Care Model. The primary goal is to determi...

What is the current status of trial NCT06555939?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-10-23. Estimated completion is 2030-09.

What conditions does trial NCT06555939 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT06555939?

The interventions under investigation include: Collaborative Care Model (BEHAVIORAL), Promoting Resilience in Stress Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT06555939?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06555939 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sickle Cell Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.